Clinical Trials | November 29, 2023
Roche expands hepatitis diagnostics portfolio
Almost 300 million people globally have chronic hepatitis B
Almost 300 million people globally have chronic hepatitis B
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Continues to Expand its Presence in South India
5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Subscribe To Our Newsletter & Stay Updated
